News about one of Penumbra 's (NYSE: PEN) development programs and an analyst's price target raise combined to boost the medical device company's stock on Monday. Its price rose by over 4%, giving the ...

For eclipse watchers not lucky enough to live on its path across the globe, you can track the celestial ... in a "fuzzy" outer shadow known as the penumbra, eclipse watchers will see a partial ...

The moon’s penumbra causes partial solar eclipses ... annular and total eclipse as the moon’s shadow moves across the globe. Corey Davis is the Collierville and Germantown reporter with ...

All the Latest Game Footage and Images from Pokemon Penumbra Moon Pokémon Supernova Sun and Penumbra Moon are mods for Pokémon Ultra Sun and Ultra Moon. Like my Rutile Ruby & Star Sapphire hacks ...

A Q&A with editorial page editor James Dao about the Boston Globe Opinion section, the editorial board, and its process for making decisions. Harris offers a vision of hope and aspiration against ...

Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the completion of enrollment in its THUNDER clinical study for patients with acute ischemic stroke. THUNDER is ...

Penumbra, the company that according to staff ... why the embolism coil wasn’t available after being contacted by the Globe. There are questions, too, that he says torment him, questions that ...

Commissions do not affect our editors' opinions or evaluations. Globe Life offers term life and whole life insurance without a medical exam, but coverage limits are significantly lower than ...

Just after market close on Tuesday, Stifel prognosticator Mathew Blackman set the tone for Penumbra on Wednesday. He launched his coverage of the specialty healthcare stock with an unambiguous buy ...

Penumbra announced that it has completed patient enrollment for a clinical trial to evaluate its Penumbra System with Thunderbolt Aspiration Tubing, a computer-assisted vacuum thrombectomy (CAVT ...

News about one of Penumbra's (NYSE: PEN) development programs and an analyst's price target raise combined to boost the medical device company's stock on Monday. Its price rose by over 4% ...